Fracture News and Research

RSS

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

30 Mar 2011

Study: Gene combinations may increase risk of hip osteoporosis in women

Women with osteoporosis in their hip suffer menopause two years earlier than healthy women, a study conducted at the University of Granada says. Additionally, although further study is required, researchers have found at least three genetic markers associated with osteoporosis in the hip in postmenopausal women.

30 Mar 2011

Atypical antipsychotics is a safe mental health medication for nursing home residents

Conventional antipsychotics, antidepressants and benzodiazepines often administered to nursing home residents are no safer than atypical antipsychotics and may carry increased risks, according to an article in CMAJ.

29 Mar 2011

Ascension launches TITAN Modular Shoulder Fracture Prosthesis

Ascension Orthopedics, Inc., a world leader in PyroCarbon orthopedic devices, announces the market release of the TITAN Modular Shoulder Fracture Prosthesis. The TITAN Modular Total Shoulder System now provides a unique way to address difficult fracture procedures. The system's modularity allows the surgeon to fit patient anatomy by independently adjusting the height of the modular body and stem without need for jigs or use of cement.

28 Mar 2011

$Osteoporotic hip and vertebral fractures have most serious impact on quality of life$

Osteoporotic hip and vertebral fractures have most serious impact on quality of life

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

25 Mar 2011

$Obese postmenopausal women as likely to fracture as non-obese women$

Obese postmenopausal women as likely to fracture as non-obese women

Obesity is widely believed to be protective against fracture, although a recent study has documented a high prevalence of obesity in postmenopausal women with fragility fracture.

25 Mar 2011

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.

25 Mar 2011

$Falls history improves accuracy of fracture prediction models$

Falls history improves accuracy of fracture prediction models

Researchers from the MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented a new study that shows how the inclusion of falls history, in addition to clinical risk factors (CRFs) and bone mineral density (BMD) values, would greatly improve the accuracy of fracture prediction models. The research findings were presented today at the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain.

25 Mar 2011

$ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro$

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs.

25 Mar 2011

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

25 Mar 2011

U.S. hospitals bill insurance companies $1.2 trillion during 2008 for inpatient care: AHRQ

U.S. community hospitals billed insurance companies and federal and state programs $1.2 trillion in 2008 for inpatient care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

23 Mar 2011

$Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty$

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.

23 Mar 2011

Onset of chronic pain more often reported following a traffic accident

Individuals with poorer health or psychological issues may be prone to developing chronic widespread pain following a traumatic event. This new research, published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), found that the onset of chronic pain was more often reported following a traffic accident than from other physically traumatic triggers.

21 Mar 2011

Englewood Hospital and Medical Center earns HealthGrades Patient Safety Excellence Award

Englewood Hospital and Medical Center was identified as a recipient of the 2011 HealthGrades Patient Safety Excellence Award, indicating that its patient safety ratings are in the top 5% of U.S. hospitals.

18 Mar 2011

$Guide to improving care of baby boomers' fragility fractures$

Guide to improving care of baby boomers' fragility fractures

Many Baby Boomers will experience a bone fracture as they age, and the current US healthcare system is not prepared to provide the necessary care required, according to a special monograph released in the January 2011 issue of Geriatric Orthopaedic Surgery and Rehabilitation (GOS), published by SAGE.

18 Mar 2011

Liquid polymer research could represent next breakthrough in stem cell therapy

At present, cartilage implants created using stem cells can only be constructed as a solid shape, acting as an interim measure before the almost inevitable need for total joint replacement.

18 Mar 2011

$HIV infection and increased fracture risk: Study$

HIV infection and increased fracture risk: Study

According to a latest study, adults between ages 25 and 54 infected with HIV, are at increased risk for bone fractures compared to the general population. Until now it was known that low bone mineral density was common in people with HIV, but no concrete proof existed.

14 Mar 2011

$HIV-infected patients may face increased risk of bone fracture$

HIV-infected patients may face increased risk of bone fracture

Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.

11 Mar 2011

Medtronic launches VERTEX SELECT CHROMALOY Plus Rods in the U.S.

Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. today announced the U.S. launch of VERTEX SELECT CHROMALOY Plus Rods.

10 Mar 2011

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.

7 Mar 2011

Fracture News and Research

Vexim granted FDA approval for COHESION bone cement

Study: Gene combinations may increase risk of hip osteoporosis in women

Atypical antipsychotics is a safe mental health medication for nursing home residents

Ascension launches TITAN Modular Shoulder Fracture Prosthesis

Osteoporotic hip and vertebral fractures have most serious impact on quality of life

Obese postmenopausal women as likely to fracture as non-obese women

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Falls history improves accuracy of fracture prediction models

ECCEO11-IOF: Total fragility fracture cost in six European countries estimated to be 31 billion Euro

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

U.S. hospitals bill insurance companies $1.2 trillion during 2008 for inpatient care: AHRQ

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Onset of chronic pain more often reported following a traffic accident

Englewood Hospital and Medical Center earns HealthGrades Patient Safety Excellence Award

Guide to improving care of baby boomers' fragility fractures

Liquid polymer research could represent next breakthrough in stem cell therapy

HIV infection and increased fracture risk: Study

HIV-infected patients may face increased risk of bone fracture

Medtronic launches VERTEX SELECT CHROMALOY Plus Rods in the U.S.

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News